Skip to main content

Table 2 Summary of parasitological and clinical outcomes among patients treated with AS + SP after 28 days of follow-up

From: Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes

Classification

Without PCR correction

PCR-corrected

Number

Proportion (95 % CI)

Number

Proportion (95 % CI)

ETF

0

0 (0)

0

0 (0)

LCF

5

5.8 (1.9, 13.0)

3

3.5 (0.7, 9.9)

LPF

0

0 (0)

0

0 (0)

ACPR

81

94.2 (87.0, 98.1)

83

96.5 (90.1, 99.3)

Total analysis

86

   

WTH

1

   

LFU

2

3.4

  

Total

89

   
  1. CI confidence interval, ACPR adequate clinical and parasitological response, ETF early treatment failure, LCF late clinical failure, LPF late parasitological failure, LFU loss to follow-up, WTH withdrawn
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us